Antonetti Capital Management’s AstraZeneca AZN Stock Holding History

Antonetti Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$13.5K	Hold	100	–	–	0.02%	187
2023 Q2	$14.3K	Hold	100	–	–	0.02%	197
2023 Q1	$13.9K	Hold	100	–	–	0.02%	198
2022 Q4	$13.6K	Hold	100	–	–	0.02%	199
2022 Q3	$11K	Hold	100	–	–	0.01%	212
2022 Q2	$13K	Sell	100 -50	-33%	-$6.56K	0.01%	208
2022 Q1	$20K	Hold	150	–	–	0.02%	203
2021 Q4	$17K	Hold	150	–	–	0.01%	254
2021 Q3	$18K	Buy	+150	New	+$17.5K	0.01%	256
2014 Q1	–	Sell	-499	Closed	-$30K	–	237
2013 Q4	$30K	Hold	499	–	–	0.03%	148
2013 Q3	$26K	Hold	499	–	–	0.03%	191
2013 Q2	$24K	Buy	+499	New	+$25.4K	0.03%	204

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return